Hanger (OTCMKTS:HNGR) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday.
According to Zacks, “Hanger Orthopedic Group Inc. develops, acquires and operates orthotic and prosthetic patient-care centers. The Orthotics & Prosthetics centers are staffed by orthotists and prosthetists, who design, fabricate, fit and supervise the use of external musculoskeletal support devices and artificial limbs. The company also manufacture custom-made and prefabricated Orthotics & Prosthetics devices and are the country’s largest distributor of Orthotics & Prosthetics components and finished Orthotics & Prosthetics patient-care products. “
A number of other brokerages also recently issued reports on HNGR. Stephens set a $17.00 price target on Hanger and gave the stock a “hold” rating in a research report on Monday, January 22nd. ValuEngine upgraded Hanger from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 3rd.
Hanger Company Profile
Hanger, Inc is a rehabilitative product and service company. The Company delivers orthotic and prosthetic (O&P) patient care, products, services and therapeutic solutions. The Company offers advanced prosthetics and orthotics, clinically differentiated programs and unsurpassed customer service. The Company comprises nine business units that serve various segments of the O&P industry.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hanger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanger and related companies with MarketBeat.com's FREE daily email newsletter.